AI reads brain tumor slides to predict genetic secrets

NCT ID NCT07263711

Recruiting now Knowledge-focused Sponsor: Nanfang Hospital, Southern Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether an artificial intelligence (AI) model can accurately predict genetic changes in gliomas, a type of brain tumor, using digital images of tissue samples. Researchers will collect pathology images and molecular test results from 2,000 adults with suspected glioma across multiple hospitals. The AI's predictions will be compared to standard lab tests to see if it can provide faster, cheaper diagnosis without extra procedures for participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: artificial intelligence (AI) model
What this could lead to: If successful, this could lead to faster and cheaper genetic testing for brain tumors, improving access to precision medicine.
What could go wrong: This is an observational study, not a treatment trial. The AI may not be accurate enough to replace standard tests, and results may vary across hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLIOMA

Contacts and locations

Locations

Nanfang Hospital, Southern Medical University
RECRUITING

Guangzhou, Guangdong, 510515, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.